English
Investors
Shareholders
EQT logo
About
Teams
Sustainability
Investments
Media
Important notice
14 February 2019
08:30 CET
Karo Intressenter AB äger cirka 66,5 procent av de utestående aktierna i Karo Pharma Aktiebolag efter utgången av den slutliga acceptfristen
#EQT VIII
#Karo Pharma
För mer information, klicka här.
EQT logo
Latest news
25 July 2024
EQT to sell its stake in fiber-to-the-home network Fiberklaar
18 July 2024
EQT AB (publ) Half-year Report 2024
16 July 2024
EQT Life Sciences invests in Asceneuron, a neurodegeneration therapeutics company, as part of USD 100 million Series C financing round
10 July 2024
EQT AB assigned ‘A-’ (Stable) credit rating by S&P
04 July 2024
EQT and Kühne Holding invest in Flix, the global travel company